Despite high pneumococcal conjugate vaccine (PCV) coverage, serotype 19F — a strain the vaccine is specifically designed to eliminate — continues circulating among infants in Cape Town's Drakenstein Child Health Study. Analysis of 617 whole-genome sequences from carriage isolates (2012–2017) identified three lineages (GPSC205, GPSC1, GPSC21) accounting for 98% of all isolates. GPSC1 and GPSC21 showed evolutionary rates of 10.3 and 5.6 substitutions per year respectively, while GPSC205 showed no detectable molecular clock signal. Spatial clustering was modest (relative risk 1.32 within 1 km), and genetic similarity correlated only weakly with geographic distance (r = 0.063), suggesting broad geographic mixing rather than contained local outbreaks.
The finding reframes how vaccine-targeted strains persist: not through geographic refuge or a single expanding resistant clone, but through the simultaneous co-circulation of multiple successful lineages that intermix across a community. This has significant implications for surveillance strategy — monitoring clone spread alone would miss this dynamic. For the broader field, it echoes patterns seen with antibiotic-resistant organisms where ecological fitness, rather than geographic isolation, sustains persistence under intervention pressure. Practically, it underscores why even well-vaccinated populations require continued genomic surveillance and may need next-generation vaccines with broader serotype coverage. Limitations include a single urban South African cohort, a carriage (not disease) focus, and a study window ending in 2017. As a preprint not yet peer-reviewed, these findings and interpretations remain provisional. Still, the methodological integration of Bayesian dating with fine-scale spatial genetics is an instructive model for pathogen surveillance globally.